Efficacy of bevacizumab (Bev) plus chemotherapy (CT) compared to CT alone in previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC): systematic review and meta-analysis.
about
Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancerAnalysis of the correlation among hypertension, the intake of β-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small cell lung cancerEfficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis.Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis.Risk profile of bevacizumab in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trials.Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.Monoclonal antibodies in lung cancer.Clinical meta-analyses of targeted therapies in adenocarcinoma.Bevacizumab in advanced NSCLC: chemotherapy partners and duration of use.Antiangiogenic agents and chemotherapy in advanced non-small cell lung cancer: a clinical perspective.First-line therapeutic options for advanced non-small-cell lung cancer in the molecular medicine era.Use of bevacizumab in recurrent glioblastoma.Anti-angiogenesis in Personalized Therapy of Lung Cancer.Statistical Primer on Biosimilar Clinical Development.Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine.Strategies targeting angiogenesis in advanced non-small cell lung cancer.[Long-term survival of a patient with advanced non-small cell lung cancer on bevacizumab therapy: case report and review of the literature].Endostar in combination with postoperative adjuvant chemotherapy prolongs the disease free survival of stage IIIA NSCLC patients with high VEGF expression.Bevacizumab in combination with different platinum-based doublets in the first-line treatment for advanced nonsquamous non-small-cell lung cancer: A network meta-analysis.The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis.Incidence and risk of thromboembolism associated with bevacizumab in patients with non-small cell lung carcinoma
P2860
Q27011293-24E278C1-5243-4D8A-9AE2-8A786C9AEC81Q33622701-5189B0CD-C7CA-42CB-854D-72D356A89515Q35545472-2DA56880-8D27-4B9A-86BD-C3A0A7F41C15Q36112303-5535892F-F2F9-4738-A003-81D8CBFEF4ACQ36871717-606B822F-028E-474E-9D0B-E6F4A00975A1Q37956392-CB9AF059-09C7-439F-9DFF-18935330299DQ38062459-872F52DC-D1FC-44CD-B361-63D2FECE3281Q38067454-B8E93B8F-C5B1-463A-BF1B-BA8B070238E0Q38077126-7D88926B-D7E4-44E9-BE50-A9E416B55A16Q38132693-050EE477-F691-4E25-865A-30A15E3AEA69Q38153445-89125E57-A1DC-4FB2-9A73-DAB29881B64BQ38221293-B6773BEC-722C-4561-9100-B164BBECF380Q38438668-E558BD3B-6CAD-4734-8806-73E3FCE9B5ADQ38669276-E04D9752-5AAC-4CD8-BBBD-EA74A67C6B61Q38696351-471F2849-4CC4-4822-ABA9-FC1F6EAAB6F8Q38829551-1101F695-B02D-49AF-9EAE-41890731B0B8Q41593429-AB6BC338-FB52-4872-B99E-F53764D16BBFQ44008655-E4FFD747-67E5-41FF-98B7-5E445BDE4063Q45124523-CAD24F60-9DF7-4755-A62A-58B1C3640881Q47420701-C7079D33-FA65-41D1-B04D-5C2F724135B1Q55083555-29162E5F-A5EE-4122-B27C-396FE6917B42Q58804445-EC67708C-E452-4F32-9C15-C688AA94EFC8
P2860
Efficacy of bevacizumab (Bev) plus chemotherapy (CT) compared to CT alone in previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC): systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of bevacizumab (Bev) ...... atic review and meta-analysis.
@en
Efficacy of bevacizumab
@nl
type
label
Efficacy of bevacizumab (Bev) ...... atic review and meta-analysis.
@en
Efficacy of bevacizumab
@nl
prefLabel
Efficacy of bevacizumab (Bev) ...... atic review and meta-analysis.
@en
Efficacy of bevacizumab
@nl
P2093
P1433
P1476
Efficacy of bevacizumab (Bev) ...... atic review and meta-analysis.
@en
P2093
Bruna Pegoretti
Enéas Faleiros
Luciana Clark
Luciano Paladini
Otávio Clark
Tobias Engel Ayer Botrel
P356
10.1016/J.LUNGCAN.2011.01.028
P577
2011-03-05T00:00:00Z